To provide for a limitation on availability of funds for Department of Health and Human Services, National Institutes of Health National Center for Advancing Translational Sciences for fiscal year 2024.

Bill 118 hr 1998, also known as the "Limitation on Availability of Funds for National Center for Advancing Translational Sciences Act," aims to place restrictions on the funding available to the National Institutes of Health's National Center for Advancing Translational Sciences (NCATS) for the fiscal year 2024.

The bill seeks to limit the amount of funds that can be allocated to NCATS, which is responsible for advancing translational research to improve the translation of scientific discoveries into tangible health benefits for patients. By placing a cap on the funding available to NCATS, the bill aims to ensure that taxpayer dollars are being used efficiently and effectively in the pursuit of translational research.

The limitations on funding outlined in the bill are intended to encourage NCATS to prioritize its research efforts and allocate resources in a manner that maximizes the impact of its work. By imposing these restrictions, Congress hopes to hold NCATS accountable for its use of taxpayer funds and ensure that the agency is working towards its mission of advancing translational research in a responsible and effective manner. Overall, Bill 118 hr 1998 represents a targeted effort to ensure that the National Center for Advancing Translational Sciences is using its resources wisely and effectively in pursuit of its important mission.